Panitumumab, oxaliplatin, folinic acid, 5-fluoruracil, irinotecan clinical trials

Comparison FOLFIRINOX Panitumumab vs mFOLFOX6 Panitumumab in RAS/B-RAF Wild-type Metastatic Colorectal Cancer Patients

This study compares two drug combinations, FOLFIRINOX with Panitumumab and mFOLFOX6 with Panitumumab, for people with advanced bowel cancer. It's for patients whose cancer cells have specific genetic features (RAS and B-RAF wild-type).